Company Information
USD
-
- (-%)
NASDAQ:FUSN, FUSION PHARMACEUTICALS INC.
Industry: Biotechnology
End of Day: 16 July 2024 GMT-4
Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing alpha therapeutics for curing cancer. It develops Targeted Alpha Therapies (TAT) together with its proprietary Fast-Clear linker technology. The firm's lead product candidate comprises FPI-1434, a monotherapy for the treatment of a variety of cancers; FPI-1966, for the treatment of head and neck and bladder cancers; and FPI-2059 among others.
Address
270 Longwood Road South
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. David D. Meek
Director
Ms. Teresa Bitetti
Director
Dr. Jeremy Bender
Director
Dr. Pablo J. Cagnoni, M.D.
Director
Dr. Christopher P. Leamon, PhD
Chief Scientific Officer
Ms. Barbara G. Duncan
Chairman of the Board/Director
Mr. John Crowley
CFO
Mr. Steven Gannon
Director
Dr. Donald A. Bergstrom, M.D.,PhD
Director
Dr. John Valliant, PhD
CEO/Director/Founder
Mr. Eric Burak, PhD
Chief Technology Officer
Dr. Philina Lee, PhD
Director
Mr. Mohit Rawat
Other Executive Officer/President
Mr. Dmitri Bobilev
Chief Medical Officer
Ownership
Institution Holdings
Federated Hermes Inc
10,886,153 (15.035%)
Federated Hermes, Inc.
10,886,153 (15.035%)
Federated Global Investment Management Corp
10,854,242 (14.991%)
Federated
10,554,242 (14.577%)
Avidity Partners Management LP
6,500,328 (8.978%)
Deerfield Mgmt LP
6,401,000 (8.840%)
FMR Inc
5,313,294 (7.338%)
HealthCap VII, LP
3,807,247 (5.258%)
Johnson & Johnson
3,670,516 (5.069%)
Orbimed Advisors, LLC
3,122,770 (4.313%)
Individual Holdings
Dr. John Valliant, PhD
318,147 (0.734%)
Mr. Steven Gannon
56,400 (0.130%)
Mr. John Crowley
10,410 (0.024%)
Mr. Mohit Rawat
12,843 (0.019%)
Dr. Christopher P. Leamon, PhD
11,957 (0.017%)
Funds Holdings
Federated Hermes Kaufmann Growth
5,480,011 (7.568%)
Federated Hermes Kaufmann
5,480,011 (7.568%)
Federated Hermes Kaufmann Sm Cp Fd
5,074,231 (7.008%)
Federated Hermes Kaufmann Small Cap Grow
5,074,231 (7.008%)
iShares Biotechnology ETF
380,777 (0.526%)
Nationwide International Small Cap Fund
162,733 (0.225%)
Federated Hermes Kaufmann Fd
161,911 (0.224%)
HealthInvest Alpha Fund
61,000 (0.084%)
VALIC Company I International Opps Fund
58,099 (0.080%)
Top Picks November 2023
46,397 (0.064%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
